What We Heard: Summary of Responses to the Notice of Intent to Restrict the Marketing and Advertising of Opioids

What We Heard: Summary of Responses to the Notice of Intent to Restrict the Marketing and Advertising of Opioids Input and advice regarding the evidence on the extent, impact, and value of the pharmaceutical industry's marketing and advertising of opioids. 2023-02-01 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetysummary of responsesnotice of intentmarketing-and-advertising of opioids What We Heard: Summary of Responses to the Notice of Intent to Restrict the Marketing and Advertising of OpioidsHTML https://www.canada.ca/en/health-canada/services/opioids/responding-canada-opioid-crisis/advertising-opioid-medications/what-we-heard.html What We Heard: Summary of Responses to the Notice of Intent to Restrict the Marketing and Advertising of OpioidsHTML https://www.canada.ca/fr/sante-canada/services/opioides/repondre-crise-opioides-canada/marketing-publicite-opioides/ce-que-nous-avons-entendu.html

Input and advice regarding the evidence on the extent, impact, and value of the pharmaceutical industry's marketing and advertising of opioids.

Data and Resources

Similar records